Skip to main content
. 2023 Aug 28;202(2):313–323. doi: 10.1007/s10549-023-07079-8

Fig. 1.

Fig. 1

A Kaplan–Meier curve of disease-free survival (DFS) according to HER2 status (HER2 null vs HER2 ultra-low, P = 0.105; HER2 ultra-low vs HER2 low, P = 0.507, log–rank) in overall breast cancer (BC) patients; B Kaplan–Meier curve of DFS according to hormone receptor (HR) status (P = 0.003) in overall BC patients